Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 239 of 5804
-
Could an antidepressant help fight brain cancer? new trial aims to find out.
Disease control Recruiting nowThere is a very urgent need to improve on the currently limited treatment options for patients with glioblastoma. Despite extensive knowledge on the molecular pathogenesis of glioblastoma obtained through genomic, transcriptional and proteomic profiling, targeted therapy efforts …
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a simple calcium injection prevent dangerous bleeding after childbirth?
Disease control Recruiting nowPostpartum hemorrhage is one of the leading causes of maternal morbidity following childbirth. Even when excessive bleeding is not clinically recognized, some women experience a significant decrease in hemoglobin levels after delivery, which may result in anemia, fatigue, delayed…
Phase: NA • Sponsor: Rambam Health Care Campus • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Sparing lymph nodes during radiation may boost immune attack on rectal cancer
Disease control Recruiting nowSafety and efficacy of Nodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab versus Short-course Radiotherapy plus Chemotherapy as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer. Com…
Phase: PHASE2 • Sponsor: Dechang Diao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New vaccine aims to tackle multiple salmonella strains at once
⭐️ VACCINE ⭐️ Not yet recruitingThe current clinical study will evaluate the GVGH Quadrivalent Pan-Salmonella vaccine for the first time in healthy adults in Africa. The purpose of the current Phase 1 study is to evaluate the safety, reactogenicity, and the immune response induced by the Pan-Salmonella vaccine.
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
Cancer drug repurposed to calm brain inflammation in autoimmune disease
Disease control Not yet recruitingThis is a multicenter, single-arm, continuous, prospective, interventional registry study designed to systematically evaluate the efficacy and safety of low-dose blinatumomab in patients with antibody-mediated refractory autoimmune encephalitis (AE) and autoimmune cerebellitis. E…
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Magnetic pulses to the brain may tame OCD symptoms
Symptom relief Not yet recruitingThe goal of this investigational study is to evaluate if the treatment using EXOMIND(BTL-699-2) device is able to improve severity of obsessive and compulsive symptoms in adults (aged 22 and older). The main question it aims to answer is: Does the treatment using EXOMIND (BTL-6…
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New program aims to stop overdose deaths among women leaving rural jails
Prevention Recruiting nowThis project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impac…
Phase: NA • Sponsor: Michele Staton • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could a fungal drug stop esophageal cancer before it starts?
Prevention Recruiting nowThis phase II trial tests how well itraconazole works in combination with the usual standard of care endoscopy with ablation for the prevention of esophageal cancer in patients who have high-risk Barrett's esophagus (BE). BE is a condition in which the lining of the esophagus cha…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Engineered t cells take on Hard-to-Treat cancers in new trial
Disease control Not yet recruitingThis phase I/IIA trial studies the side effects and best dose of gene-modified T cells when given with or without decitabine, and to see how well they work in treating patients with malignancies expressing cancer-testis antigens.
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New acid blocker could shield heart patients from stomach bleeding
Disease control Recruiting nowThis study aims to compare the clinical outcomes between routine use of potassium competitive acid blocker (P-CAB) and guideline-directed gastrointestinal (GI) protection strategy in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PC…
Phase: PHASE3 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for myeloma patients: drug combo aims to keep cancer at bay
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of cevostamab in combination with pomalidomide and dexamethasone (CevosPd) versus standard of care (SOC) in participants with multiple myeloma (MM) who have received one to three prior lines of therapy and have been e…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New oral drug aims to tame PKU's toxic protein buildup
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).
Phase: PHASE2 • Sponsor: Maze Therapeutics • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Spinal-Fluid injection targets Hard-to-Reach lung cancer spread
Disease control Not yet recruitingThis study is a Phase I, single-arm, single-center, dose-escalation clinical trial designed to investigate the safety and efficacy of intrathecal injection of sacituzumab tirumotecan (sac-TMT) in patients with EGFR mutation-positive non-small cell lung cancer and leptomeningeal m…
Phase: PHASE1 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New trial seeks best chemo strategy for childhood muscle cancer
Disease control Not yet recruitingThis phase III trial compares higher dose chemotherapy, with vincristine, dactinomycin and cyclophosphamide, over a shorter amount of time to lower dose chemotherapy plus maintenance, with vincristine, dactinomycin, cyclophosphamide, irinotecan and vinorelbine, over a longer amou…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for Late-Stroke patients: drug trial uses advanced imaging to guide treatment
Disease control Recruiting nowThis study aims to address the existing clinical challenges by introducing high-resolution magnetic resonance vessel wall imaging (HR-MRI), an advanced imaging technology, to achieve precise etiological classification in patients with acute ischemic stroke (AIS) beyond the time w…
Phase: PHASE3 • Sponsor: Weifang Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New obesity drug CagriSema heads to phase 3 trial
Disease control TerminatedThis study is being done to find out how well a medicine called CagriSema helps people with overweight or obesity lose weight. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. In this study the sponsor will compare two version of Cagri…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Herbal dripping pills aim to boost exercise capacity in heart failure
Disease control Recruiting nowThis trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood Stasis).
Phase: PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug could boost stroke recovery by calming brain inflammation
Disease control Recruiting nowStroke remains a major global health burden, with acute ischemic stroke (AIS) accounting for more than 65% of all cases. Endovascular thrombectomy (EVT) has been established as a standard treatment for large vessel occlusion (LVO) stroke; however, "futile recanalization" remains …
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New combo therapy targets rare lung cancer mutation
Disease control Recruiting nowThis is a prospective, single-arm, Phase II clinical study aimed at evaluating the efficacy and safety of 160mg fimonertinib in combination with definitive radiotherapy for patients with EGFR uncommon driver mutation-positive, Stage III unresectable lung adenocarcinoma. The prima…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill could tame lupus flares
Disease control Recruiting nowTo assess the efficacy and safety of TQH3906 in treating systemic lupus erythematosus.
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC